US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 12, 2019 (7 years ago)

Albuterol 2.5mg / Ipratropium 0.75mg /Budesonide 0.25mg

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls

What was recalled

Albuterol 2.5mg / Ipratropium 0.75mg /Budesonide 0.25mg, 3ML Vial, For Inhalation Only, Shake Well, Conversio Health, San Luis Obispo, CA 93401.

Recalling firm
Integrated Health Concepts Inc. dba Conversio Health
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0512-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Albuterol recalls

See all
Class III · Low risk Ongoing

Albuterol Sulfate

Reason Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.

Cipla USA, Inc. NDC 69097-142-60 D-0593-2025
Class II · Moderate risk Ongoing

Airsupra

Reason Defective delivery system

AsttraZeneca Pharmaceuticals LP NDC 0310-9080-12 D-0444-2025
Class I · High risk Terminated

Albuterol Sulfate Inhalation Aerosol

Reason Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).

Cipla USA, Inc. NDC 69097-142-60 D-0938-2023